Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.
In 2008, dihydroartemisinin (DHA)-piperaquine (PPQ) became the first-line treatment for uncomplicated Plasmodium falciparum malaria in western Cambodia. Recent reports of increased treatment failure rates after DHA-PPQ therapy in this region suggest that parasite resistance to DHA, PPQ, or both is n...
Príomhchruthaitheoirí: | Lim, P, Dek, D, Try, V, Eastman, RT, Chy, S, Sreng, S, Suon, S, Mao, S, Sopha, C, Sam, B, Ashley, E, Miotto, O, Dondorp, A, White, N, Su, X, Char, M, Anderson, J, Amaratunga, C, Menard, D, Fairhurst, R |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2013
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Plasmodium falciparum founder populations in western Cambodia have reduced artemisinin sensitivity in vitro.
de réir: Amaratunga, C, et al.
Foilsithe / Cruthaithe: (2014) -
Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study
de réir: Amaratunga, C, et al.
Foilsithe / Cruthaithe: (2016) -
Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
de réir: Amaratunga, C, et al.
Foilsithe / Cruthaithe: (2016) -
Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study
de réir: Kwiatkowski, D, et al.
Foilsithe / Cruthaithe: (2016) -
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia.
de réir: Miotto, O, et al.
Foilsithe / Cruthaithe: (2013)